Development of anticancer agents targeting the Wnt/β-catenin signaling

被引：1

作者：

Zhang, Xiangqian ^{[1
]}

Hao, Jijun ^{[2
,3
]}

机构：

[1] Yanan Univ, Coll Life Sci, Yanan 716000, Shaanxi, Peoples R China

[2] Western Univ Hlth Sci, Coll Vet Med, Pomona, CA 91766 USA

[3] Western Univ Hlth Sci, Grad Coll Biomed Sci, Pomona, CA 91766 USA

来源：

AMERICAN JOURNAL OF CANCER RESEARCH | 2015年 / 5卷 / 08期

关键词：

Wnt/beta-catenin signaling; beta-catenin; cancer; small molecules; biologic agents; therapeutic; safety and clinic; SMALL-MOLECULE INHIBITOR; SEGMENT POLARITY GENE; BETA-CATENIN; WNT PATHWAY; STEM-CELLS; SMALL-INTESTINE; PDZ DOMAIN; FRIZZLED RECEPTORS; COLORECTAL-CANCER; PROTEIN;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Wnt/beta-catenin signaling plays indispensable roles in both embryonic development and adult homeostasis. Abnormal regulation of this pathway is implicated in many types of cancer. Consequently, substantial efforts have made to develop therapeutic agents as anticancer drugs by specifically targeting the Wnt/beta-catenin pathway. Here we systematically review the potential therapeutic agents that have been developed to date for inhibition of the Wnt/beta-catenin cascade as well as current status of clinical trials of some of these agents.

引用

页码：2344 / 2360

页数：17

共 50 条

[31] WNT/catenin signaling modulates development of taste primordia
Thirumangalathu, S.
Stoick-Cooper, C. L.
Moon, R. T.
Barlow, L. A.
CHEMICAL SENSES, 2006, 31 (05) : A128 - A128
[32] Wnt/β-catenin Signaling in Oral Tissue Development and Disease
Liu, F.
Millar, S. E.
JOURNAL OF DENTAL RESEARCH, 2010, 89 (04) : 318 - 330
[33] Microtubule-targeting agents impair kinesin-2-dependent nuclear transport of β-catenin: Evidence of inhibition of Wnt/β-catenin signaling as an important antitumor mechanism of microtubule-targeting agents
Kumari, Anuradha
Shriwas, Omprakash
Sisodiya, Shailendra
Santra, Manas K.
Guchhait, Sankar K.
Dash, Rupesh
Panda, Dulal
FASEB JOURNAL, 2021, 35 (04):
[34] Wnt/β-catenin signaling in colorectal cancer: Is therapeutic targeting even possible?
Disoma, Cyrollah
Zhou, Yuzheng
Li, Shanni
Peng, Jian
Xia, Zanxian
BIOCHIMIE, 2022, 195 : 39 - 53
[35] Anticancer agents targeting signaling molecules and cancer cell environment: Challenges for drug development?
Gelmon, KA
Eisenhauer, EA
Harris, AL
Ratain, MJ
Workman, P
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (15) : 1281 - 1287
[36] Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer
Cheng, Xiaofei
Xu, Xiangming
Chen, Dong
Zhao, Feng
Wang, Weilin
BIOMEDICINE & PHARMACOTHERAPY, 2019, 110 : 473 - 481
[37] Advances in targeting the WNT/13-catenin signaling pathway in cancer
Chatterjee, Avradip
Paul, Sayan
Bisht, Bharti
Bhattacharya, Shelley
Sivasubramaniam, Sudhakar
Paul, Manash K.
DRUG DISCOVERY TODAY, 2022, 27 (01) : 82 - 101
[38] Targeting Wnt/β-catenin signaling by microRNAs as a therapeutic approach in chemoresistant osteosarcoma
Hosseini, Foroogh
Alemi, Forough
Malakoti, Faezeh
Mahmoodpoor, Ata
Younesi, Simin
Yousefi, Bahman
Asemi, Zatollah
BIOCHEMICAL PHARMACOLOGY, 2021, 193
[39] Direct targeting of β-catenin in the Wnt signaling pathway: Current progress and perspectives
Wang, Zhen
Li, Zilu
Ji, Haitao
MEDICINAL RESEARCH REVIEWS, 2021, 41 (04) : 2109 - 2129
[40] Nitazoxanide and Cancer Drug Resistance: Targeting Wnt/β-catenin Signaling Pathway
Hemmati-Dinarvand, Mohsen
Ahmadvand, Hassan
Seghatoleslam, Atefeh
ARCHIVES OF MEDICAL RESEARCH, 2022, 53 (03) : 263 - 270

← 1 2 3 4 5 →